Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea.

Thirty-nine patients with uncomplicated gonorrhea were randomized to receive single, oral 50-, 100-, or 200-mg doses of trovafloxacin (CP-99,219), a new quinolone antibiotic. All 31 evaluable patients were cured of infection. Trovafloxacin was well tolerated. The trovafloxacin MICs at which 50 and 9...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Hook, E W, Pinson, G B, Blalock, C J, Johnson, R B
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163403/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8807070/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.7.1720
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!